SMTI
Income statement / Annual
Last year (2024), Sanara MedTech Inc.'s total revenue was $86.67 M,
an increase of 33.36% from the previous year.
In 2024, Sanara MedTech Inc.'s net income was -$9.66 M.
See Sanara MedTech Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$86.67 M |
$64.99 M |
$45.84 M |
$24.14 M |
$15.59 M |
$11.77 M |
$5.84 M |
$6.30 M |
$5.51 M |
$3.37 M |
| Cost of Revenue |
$8.14 M
|
$7.85 M
|
$6.36 M
|
$2.31 M
|
$1.62 M
|
$1.21 M
|
$507.42 K
|
$806.04 K
|
$943.58 K
|
$891.97 K
|
| Gross Profit |
$78.53 M
|
$57.14 M
|
$39.48 M
|
$21.83 M
|
$13.97 M
|
$10.56 M
|
$5.33 M
|
$5.50 M
|
$4.56 M
|
$2.48 M
|
| Gross Profit Ratio |
0.91
|
0.88
|
0.86
|
0.9
|
0.9
|
0.9
|
0.91
|
0.87
|
0.83
|
0.74
|
| Research and Development Expenses |
$5.70 M
|
$4.13 M
|
$3.37 M
|
$558.70 K
|
$40.19 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$45.98 M
|
$28.05 M
|
$18.67 M
|
$13.07 M
|
$5.74 M
|
$5.28 M
|
$4.76 M
|
$3.39 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$76.56 M
|
$56.99 M
|
$45.98 M
|
$28.05 M
|
$18.67 M
|
$13.07 M
|
$5.74 M
|
$5.28 M
|
$4.76 M
|
$3.39 M
|
| Other Expenses |
$2.98 M
|
$225.13 K
|
$2.66 M
|
$596.98 K
|
$291.37 K
|
$229.95 K
|
-$22.08 K
|
$125.00
|
$21.00
|
$60.03 K
|
| Operating Expenses |
$85.25 M
|
$61.35 M
|
$52.00 M
|
$29.21 M
|
$19.00 M
|
$13.30 M
|
$5.82 M
|
$5.36 M
|
$4.84 M
|
$3.45 M
|
| Cost And Expenses |
$93.39 M
|
$69.20 M
|
$58.36 M
|
$31.52 M
|
$20.62 M
|
$14.51 M
|
$6.33 M
|
$6.16 M
|
$5.78 M
|
$4.34 M
|
| Interest Income |
$21.98 K
|
$0.00
|
$284.75 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$3.13 M
|
$475.78 K
|
$284.75 K
|
$711.00
|
$11.53 K
|
$105.92 K
|
$86.59 K
|
$126.83 K
|
$174.49 K
|
$176.89 K
|
| Depreciation & Amortization |
$4.92 M
|
$3.68 M
|
$2.37 M
|
$771.93 K
|
$291.37 K
|
$119.95 K
|
$56.94 K
|
$80.65 K
|
$60.88 K
|
$60.03 K
|
| EBITDA |
-$1.86 M |
-$289.10 K |
-$11.57 M |
-$7.22 M |
-$4.14 M |
-$2.61 M |
-$417.97 K |
$538.78 K |
-$180.37 K |
-$1.10 M |
| EBITDA Ratio |
-0.02
|
-0
|
-0.25
|
-0.3
|
-0.27
|
-0.22
|
-0.07
|
0.09
|
-0.03
|
-0.33
|
| Operating Income Ratio |
-0.08
|
-0.06
|
-0.27
|
-0.31
|
-0.32
|
-0.23
|
-0.09
|
0.02
|
-0.05
|
-0.29
|
| Total Other Income/Expenses Net |
-$3.20 M
|
-$224.75 K
|
-$1.42 M
|
-$617.64 K
|
$589.47 K
|
-$95.72 K
|
-$98.71 K
|
$210.87 K
|
-$143.61 K
|
-$375.47 K
|
| Income Before Tax |
-$9.91 M
|
-$4.44 M
|
-$13.94 M
|
-$7.99 M
|
-$4.45 M
|
-$2.84 M
|
-$600.57 K
|
$331.31 K
|
-$415.75 K
|
-$1.34 M
|
| Income Before Tax Ratio |
-0.11
|
-0.07
|
-0.3
|
-0.33
|
-0.29
|
-0.24
|
-0.1
|
0.05
|
-0.08
|
-0.4
|
| Income Tax Expense |
$0.00
|
$0.00
|
-$5.84 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$9.66 M
|
-$4.30 M
|
-$7.94 M
|
-$7.92 M
|
-$4.36 M
|
-$2.81 M
|
-$600.57 K
|
$331.31 K
|
-$415.75 K
|
-$1.34 M
|
| Net Income Ratio |
-0.11
|
-0.07
|
-0.17
|
-0.33
|
-0.28
|
-0.24
|
-0.1
|
0.05
|
-0.08
|
-0.4
|
| EPS |
-1.14 |
-0.52 |
-1 |
-1.08 |
-0.76 |
-1.37 |
-0.28 |
0.17 |
-0.38 |
-1.26 |
| EPS Diluted |
-1.14 |
-0.52 |
-1 |
-1.08 |
-0.76 |
-1.37 |
-0.28 |
0.0922 |
-0.38 |
-1.25 |
| Weighted Average Shares Out |
$8.48 M
|
$8.28 M
|
$7.91 M
|
$7.34 M
|
$5.73 M
|
$2.13 M
|
$2.17 M
|
$1.11 M
|
$1.09 M
|
$1.07 M
|
| Weighted Average Shares Out Diluted |
$8.48 M
|
$8.28 M
|
$7.91 M
|
$7.34 M
|
$5.73 M
|
$2.13 M
|
$2.17 M
|
$2.09 M
|
$1.10 M
|
$1.07 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
